Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With ImmuCell
Date:2/11/2008

NEW YORK, Feb. 11 /PRNewswire/ -- On February 8, Michael F. Brigham, President and CEO of ImmuCell Corporation (Nasdaq: ICCC) (http://www.immucell.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or by entering the company's ticker symbol in the Search Archive window.

About ImmuCell:

ImmuCell Corporation is a biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at http://www.immucell.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from ImmuCell Corporation for the dissemination of this press release. For a complete list of our advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
2. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
3. Synvista Therapeutics to be Featured on Wallst.net
4. WallSt.net Announces Upcoming Interview With CEO of Biomoda
5. WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix
8. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
9. Nventa updates progress of cervical dysplasia trial with new HspE7
10. SGX Pharmaceuticals Updates Date of Presentation at the BIO InvestorForum 2007
11. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):